{"id":"grastofil","safety":{"commonSideEffects":[{"rate":null,"effect":"Bone pain"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1201567","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Grastofil binds to G-CSF receptors on hematopoietic progenitor cells, promoting their differentiation and proliferation into mature neutrophils. By increasing circulating neutrophil counts, it reduces the duration and severity of chemotherapy-induced neutropenia, thereby lowering the incidence of febrile neutropenia and associated infections in cancer patients.","oneSentence":"Grastofil is a granulocyte colony-stimulating factor (G-CSF) analog that stimulates the production and release of neutrophils from bone marrow to reduce infection risk in cancer patients receiving chemotherapy.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:14:16.177Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chemotherapy-induced neutropenia in cancer patients"}]},"trialDetails":[{"nctId":"NCT06116734","phase":"PHASE3","title":"Lapelga vs Gastrofil","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-11-01","conditions":"Multiple Myeloma, Lymphoma, Engagement, Patient","enrollment":74}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["biosimilar filgrastim"],"phase":"phase_3","status":"active","brandName":"Grastofil®","genericName":"Grastofil®","companyName":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","companyId":"london-health-sciences-centre-research-institute-or-lawson-research-institute-of","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Grastofil is a granulocyte colony-stimulating factor (G-CSF) analog that stimulates the production and release of neutrophils from bone marrow to reduce infection risk in cancer patients receiving chemotherapy. Used for Chemotherapy-induced neutropenia in cancer patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}